1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThe Assistance Fund: Sickle Cell Disease (SCD) is sponsored by The Assistance Fund. This program provides essential financial support to patients prescribed with FDA-approved treatments for Sickle Cell Disease. It offers copay and financial assistance to eligible U.
S. citizens or permanent residents diagnosed with SCD.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Casgevy Coupon 2026 | Savings Card | PrescriberPoint Assistance Fund: Sickle Cell Disease (SCD): Waitlist About The Assistance Fund: Sickle Cell Disease (SCD): Waitlist program provides essential financial support to patients prescribed with FDA-approved treatments such as Ferriprox, Adakveo, Endari, Siklos, and others.
This program offers copay and financial assistance to eligible U.S. citizens or permanent residents diagnosed with Sickle Cell Disease, ensuring they can afford necessary treatments and related medical expenses. With opportunities for conditional approval and coverage of off-label drugs, the Assistance Fund: Sickle Cell Disease (SCD): Waitlist ensures patients receive the care needed without financial burden.
Insurance requirements : Commercially insured, Medicare / Medicaid Program Requirements • Valid only for residents in the US and Puerto Rico • Enrollment Required: Yes • Activation Required: No Program Details • Please note the following: • 1. Copay grant programs provide assistance for copays, coinsurance, and deductibles for FDAapproved treatment for the disease named in the disease program ONLY • 2.
Financial assistance grant programs provide assistance for other eligible outofpocket costs, such as health insurance premiums and incidental medical expenses, in addition to copay, coinsurance, and deductible assistance on FDAapproved treatment for the disease named in the disease program • 3.
This fund may cover offlabel drugs • Copay and Financial assistance can be utilized by any innetwork pharmacy or site of care able to dispense the medication or provide treatment • Program offers conditional approval of 30 days of immediate assistance for open programs where funding is available • Patients will be asked to provide and verify demographic, insurance, and financial information (additional documentation may be requested) • Approved patients will be granted assistance through the end of the calendar year unless otherwise specified for the applicable program
According to the current listing, eligibility includes: Eligible U. S. citizens or permanent residents diagnosed with Sickle Cell Disease, who are commercially insured or have Medicare/Medicaid. Applicants must meet medical, financial, and insurance eligibility requirements. Confirm the full requirements in the official notice before applying.
The Assistance Fund: Sickle Cell Disease (SCD) is funded by The Assistance Fund. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
On September 16, 2026, the First Circuit granted HUD an emergency stay of the order that had erased the FY2026 Continuum of Care competition. HUD reopened e-snaps on September 18 with a September 30, 8:00 PM ET deadline, one technical correction shortening applicant notification from 15 days to 7, and a waiver letting private nonprofits administer rental assistance. Here is what the stay does and does not decide, why your award may still be provisional, and the exact sequence to run in the days you have left.
Read articleUSDA-NIFA-WAMS-011117 posted September 4, 2026 with $1,905,210 across an estimated 12 awards of $25,000 to $200,000, closing September 14, 2026. The opportunity title is now simply "Science, Technology, Engineering, and Mathematics Fields." Assistance listing 10.318 still reads "Women and Minorities in Science, Technology, Engineering, and Mathematics Fields" — and NIFA's own program page says the program is not funded for FY2026.
Read articleThe Pax Silica Artificial Intelligence Assistance Project (DFOP0019182) offered awards from $1 million to $50 million to build a cryptographic credentialing and provenance system for semiconductors, AI infrastructure, and critical minerals moving through Panama's ports — with a second phase expanding to the rest of the Pax Silica bloc. For-profits were eligible as primes. Here's what the NOFO signals about where foreign assistance money is going.
Read article